News Focus
News Focus
Followers 40
Posts 3798
Boards Moderated 0
Alias Born 12/07/2020

Re: tunnelvisionofplenty post# 745508

Wednesday, 02/12/2025 11:36:31 AM

Wednesday, February 12, 2025 11:36:31 AM

Post# of 817835
Gozetotide approved for the treatment of prostate cancer.

The new marketing authorisation was granted on 12 February 2025 to TELIX PHARMACEUTICALS (UK) LIMITED
This product was submitted and approved via a national procedure. 

https://www.gov.uk/government/news/gozetotide-approved-for-the-treatment-of-prostate-cancer?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=a2beb48c-e343-4a08-a392-bb0accc42d50&utm_content=immediately
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News